EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The nasal microbiota is a potential diagnostic biomarker for sepsis in critical care units

XiLan Tan iD, Haiyue Liu, Wen Qiu, Zewen Li, Shuang Ge, Yuemei Luo, Nianyi Zeng, Manjun Chen, Qiqi Zhou, Shumin Cai, Jun Long, Zhongran Cen und 3 weitere

Microbiology Spectrum · 2024

DOI: 10.1128/spectrum.03441-23 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiology Spectrum, 2024. Verfasst von XiLan Tan und 14 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infection Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou, China. Hauptthemen laut MEDLINE: Sepsis, Intensive Care Units, Microbiota, RNA, Ribosomal, 16S. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: GDSTC | Basic and Applied Basic Research Foundation of Guangdong Province (), MOST | National Natural Science Foundation of China (NSFC).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study aimed to characterize the composition of intestinal and nasal microbiota in septic patients and identify potential microbial biomarkers for diagnosis. A total of 157 subjects, including 89 with sepsis, were enrolled from the affiliated hospital. Nasal swabs and fecal specimens were collected from septic and non-septic patients in the intensive care unit (ICU) and Department of Respiratory and Critical Care Medicine. DNA was extracted, and the V4 region of the 16S rRNA gene was amplified and sequenced using Illumina technology. Bioinformatics analysis, statistical processing, and machine learning techniques were employed to differentiate between septic and non-septic patients. The nasal microbiota of septic patients exhibited significantly lower community richness ( P = 0.002) and distinct compositions ( P = 0.001) compared to non-septic patients. Corynebacterium , Staphylococcus , Acinetobacter , and Pseudomonas were identified as enriched genera in the nasal microbiota of septic patients. The constructed machine learning model achieved an area under the curve (AUC) of 89.08, indicating its efficacy in differentiating septic and non-septic patients. Importantly, model validation demonstrated the effectiveness of the nasal microecological diagnosis prediction model with an AUC of 84.79, while the gut microecological diagnosis prediction model had poor predictive performance (AUC = 49.24). The nasal microbiota of ICU patients effectively distinguishes sepsis from non-septic cases and outperforms the gut microbiota. These findings have implications for the development of diagnostic strategies and advancements in critical care medicine. IMPORTANCE The important clinical significance of this study is that it compared the intestinal and nasal microbiota of sepsis with non-sepsis patients and determined that the nasal microbiota is more effective than the intestinal microbiota in distinguishing patients with sepsis from those without sepsis, based on the difference in the lines of nasal specimens collected.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SepsisIntensive Care UnitsMicrobiotaRNA, Ribosomal, 16SBiomarkersBacteriaFecesHumansMaleFemaleMiddle AgedAgedAdultMachine LearningGastrointestinal MicrobiomeNoseCorynebacteriumAcinetobacterAged, 80 and overStaphylococcusPseudomonas

Stichwörter der Autor:innen

16S rRNAgut microbiotanasal microbiotasepsis

Substanzen

RNA, Ribosomal, 16SBiomarkers

Autor:innen und Institutionen

  • Division of Infection Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
  • State Key Laboratory of Organ Failure Research, Division of Laboratory Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
  • Xiamen Key Laboratory of Genetic Testing, The department of laboratory medicine, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China.
  • Microbiome Medicine Center, Department of Laboratory Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, China.
  • Department of Intensive Care Medicine, Nanfang Hospital, Southern Medical University, Guagnzhou, China.
  • Division of Intensive Care Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou, China.

ORCID-Profile: XiLan Tan, Hongwei Zhou, Xiaolong He

Förderung

  • GDSTC | Basic and Applied Basic Research Foundation of Guangdong Province ()
  • MOST | National Natural Science Foundation of China (NSFC)

Zitieren

APA

Tan, X., Liu, H., Qiu, W., Li, Z., Ge, S., Luo, Y., Zeng, N., Chen, M., Zhou, Q., Cai, S., Long, J., Cen, Z., Su, J., Zhou, H., & He, X. (2024). The nasal microbiota is a potential diagnostic biomarker for sepsis in critical care units. Microbiology Spectrum. https://doi.org/10.1128/spectrum.03441-23

Vancouver

Tan X, Liu H, Qiu W, Li Z, Ge S, Luo Y, et al. The nasal microbiota is a potential diagnostic biomarker for sepsis in critical care units. Microbiology Spectrum. 2024. doi:10.1128/spectrum.03441-23

BibTeX
@article{Tan2024,
  author = {Tan, XiLan and Liu, Haiyue and Qiu, Wen and Li, Zewen and Ge, Shuang and Luo, Yuemei and Zeng, Nianyi and Chen, Manjun and Zhou, Qiqi and Cai, Shumin and Long, Jun and Cen, Zhongran and Su, Jin and Zhou, Hongwei and He, Xiaolong},
  title = {The nasal microbiota is a potential diagnostic biomarker for sepsis in critical care units},
  journal = {Microbiology Spectrum},
  year = {2024},
  doi = {10.1128/spectrum.03441-23}
}
Kostenlos starten →